Jane Street Group, LLC Solid Biosciences Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$2.38 - $3.77 $88,369 - $139,980	-37,130 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $189,943 - $299,881	-54,425 Reduced 59.45%	37,130 $136,000
Q1 2021 May 18, 2021	BUY	$5.37 - $10.72 $337,155 - $673,055	62,785 Added 218.23%	91,555 $506,000
Q4 2020 Feb 17, 2021	BUY	$3.08 - $7.79 $88,611 - $224,118	28,770 New	28,770 $218,000
Q3 2020 Nov 17, 2020	SELL	$2.02 - $3.08 $43,535 - $66,380	-21,552 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$2.1 - $3.42 $45,259 - $73,707	21,552 New	21,552 $64,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.